Drugmakers Have Pledged to Invest $350 Billion in U.S. After Tariff Threat

URLhttps://www.wsj.com/health/pharma/us-pharmaceutica
SourceWall Street Journal
Date Published09/16/2025
Author NamePeter Loftus

Additional Reshoring Information:

Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2025
Domestically, the work will be done:In-house
Capital investment ($):1200
Country(ies) from which reshored:United Kingdom
City reshored to:Philadelphia
State(s) reshored to:PA
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharmaceuticals
What non-domestic negative factors made offshoring less attractive?Supply chain interruption, Tariffs
Find Reshoring Articles